Aurora Cannabis (ACB) EBIT (2018 - 2025)
Historic EBIT for Aurora Cannabis (ACB) over the last 8 years, with Q4 2025 value amounting to $14.5 million.
- Aurora Cannabis' EBIT fell 4495.59% to $14.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$590283.7, marking a year-over-year decrease of 10265.46%. This contributed to the annual value of $3.4 million for FY2025, which is 11030.28% up from last year.
- As of Q4 2025, Aurora Cannabis' EBIT stood at $14.5 million, which was down 4495.59% from $2.4 million recorded in Q3 2025.
- Aurora Cannabis' EBIT's 5-year high stood at $26.4 million during Q4 2024, with a 5-year trough of -$112.9 million in Q1 2021.
- Moreover, its 5-year median value for EBIT was -$11.8 million (2023), whereas its average is -$21.7 million.
- Its EBIT has fluctuated over the past 5 years, first surged by 30412.82% in 2024, then plummeted by 89891.83% in 2025.
- Over the past 5 years, Aurora Cannabis' EBIT (Quarter) stood at -$44.3 million in 2021, then decreased by 11.43% to -$49.3 million in 2022, then soared by 73.79% to -$12.9 million in 2023, then surged by 304.13% to $26.4 million in 2024, then tumbled by 44.96% to $14.5 million in 2025.
- Its EBIT stands at $14.5 million for Q4 2025, versus $2.4 million for Q3 2025 and -$749137.6 for Q2 2025.